MRI, MRS scans reveal who will lose weight
MRI and MR spectroscopy can identify fat distribution within the body and thus determine who will benefit most from lifestyle changes.
MRI and MR spectroscopy can identify fat distribution within the body and thus determine who will benefit most from lifestyle changes. Study subjects whose health improved the most after lifestyle changes started out with lower baseline levels of abdominal and liver fat.
German researchers performed MRI and MR spectroscopy on 243 individuals prior to and nine months after a lifestyle intervention (weight loss of 5%, reduced fat intake, and moderate physical activity). Each of the participants was considered at risk of developing type 2 diabetes as a result of obesity.
After nine months, insulin sensitivity improved in 71% of the men and 58% of the women. Individuals with improved insulin sensitivity lost significant amounts of abdominal fat (19% for women and 20% for men) and liver fat (35% for women and 44% for men) (Radiol doi:10.1148/radiol.10092284).
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 3
August 1st 2025In the third of a three-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, discuss strategies for maintaining the integrity of time-out procedures and communication with remote MRI scanning.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
August 1st 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
Twenty Years of CT Colonography for Colorectal Cancer Screening: What the Research Reveals
August 1st 2025Computed tomography colonography (CTC) demonstrated a 91.6 percent positive predictive value (PPV) for polyps > 6 mm, according to new research involving over 9,000 patients who underwent CTC for primary asymptomatic colorectal cancer screening.
